WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Stock Ownership - Who owns Repare Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Repare Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve ForteEVP CHIEF FINANCIAL OFFICER2025-03-126,884$1.14
$7.85kSell
Maria KoehlerEVP CHIEF MEDICAL OFFICER2025-03-123,596$1.14
$4.10kSell
Lloyd Mitchell SegalPRESIDENT AND CEO2025-03-1221,179$1.14
$24.14kSell
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2025-03-125,611$1.14
$6.40kSell

1 of 1

RPTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPTX insiders and whales buy or sell their stock.

RPTX Shareholders

What type of owners hold Repare Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ansbert Gadicke9.05%3,882,485$6.06MInsider
Davis Jerel8.57%3,675,793$5.73MInsider
Versant Ventures V LLC8.51%3,650,662$5.70MInsider
Versant Vantage I LP8.51%3,650,662$5.70MInsider
Blue Owl Capital Holdings LP8.03%3,443,659$5.37MInstitution
Mpm Bioventures 2014 LP7.00%3,003,772$4.69MInsider
Versant Venture Management LLC6.17%2,646,657$4.13MInstitution
Todd Foley5.23%2,242,636$3.50MInsider
Redmile Group LLC3.70%1,586,174$2.47MInsider
Acadian Asset Management LLC1.59%681,180$1.06MInstitution

1 of 3

RPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPTX19.70%54.27%Net Selling
CNTX21.30%1.46%Net BuyingNet Buying
ARTV6.38%64.44%
STRO20.73%18.21%Net Selling
APLT24.31%8.42%Net Selling
View Top Biotech Stocks

Repare Therapeutics Stock Ownership FAQ

Who owns Repare Therapeutics?

Repare Therapeutics (NASDAQ: RPTX) is owned by 19.70% institutional shareholders, 54.27% Repare Therapeutics insiders, and 26.03% retail investors. Ansbert Gadicke is the largest individual Repare Therapeutics shareholder, owning 3.88M shares representing 9.05% of the company. Ansbert Gadicke's Repare Therapeutics shares are currently valued at $6.06M.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.